Orderingången accelererade och den nådde en ny nivå - igen.
Starkt kvartal Hyresintäkterna i Q2'22 uppgick till EUR 7,4m (EUR 5,4m i Q2'21), drivet av större fa...
Svagt förvaltningsresultat Hyresintäkterna uppgick till 1 878 mkr och driftsnettot uppgick till 1 29...
Redeye states that Addnode had a strong Q2 where sales and EBITA beat our forecasts with ~9%.
Redeye’s first comments following this morning’s Q2 report for Tagmaster.
Redeye is impressed by the strong numbers. Particularly gross margins of 45% which is significantly ...
Sales 17% y-o-y but -4% vs. ABGSCe Expect negative estimate revisions on higher costs Share is tradi...
CORRECTED NUMBER Redeye maintains its valuation and positive view of Orexo after the Q2 report.
8% organic growth (cons 8%) and in line sales… …while higher costs caused ~20% adj.
Organic growth remains in healthy high-single digits Salaries and travel costs reduce adj.
Redeye retains its positive view of Formpipe. While the headline numbers look weak at first glance, ...
Vitrolife continues to improve organic growth and margins with good balance support from all regions...
Redeye comments on Carasent's Q2 2022 report, which came in slightly lower than our estimates on the...
Sales came in 3% above ABGSCe Normalised EBIT of SEK -6.
Sales 7% above cons, EBITDA 8% Streamlining in Genetic Services Cons ‘22e EBITDA to come up ~5% Q2 ...
Redeye states that the Q2 report was soft in terms of sales, but that profitability held up well des...
Redeye comments on AVTECH's key figures, which showed strong and profitable growth, with revenue up ...
Redeye retains its positive view on Proact following a strong Q2 report with high System sales with ...
Redeye comments on Beijer Group's Q2 2022, which showed all-time highs in order intake, sales, and E...
21% organic growth in Q2 drove a 21% adj. EBITA beat System sales was the main driver, adj.
